FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/09/036349 [Registered on: 08/09/2021] Trial Registered Prospectively
Last Modified On: 13/06/2026
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Sensory Modulation and Occupational Participation in Schizophrenia 
Scientific Title of Study   Relationship Between Sensory Modulation and Occupational Participation in Individuals with Schizophrenia 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Shalini Quadros 
Designation  Assistant Professor - Senior Scale 
Affiliation  Manipal College of Health Professions 
Address  Department Of Occupational Therapy, MCHP, MAHE, Manipal
Department Of Occupational Therapy, MCHP, MAHE, Manipal
Udupi
KARNATAKA
576104
India 
Phone  08197579700  
Fax    
Email  shalini.quadros@manipal.edu  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ravindra Munoli 
Designation  Associate Professor 
Affiliation  Kasturba Medical College, MAHE 
Address  Department Of Psychiatry, KMC, MAHE, Manipal
Department Of Psychiatry, KMC, MAHE, Manipal
Udupi
KARNATAKA
576104
India 
Phone  09972028881  
Fax    
Email  ravindra.nm@manipal.edu  
 
Details of Contact Person
Public Query
 
Name  Shalini Quadros 
Designation  Assistant Professor - Senior Scale 
Affiliation  Manipal College of Health Professions 
Address  Department Of Occupational Therapy, MCHP, MAHE, Manipal
Department Of Occupational Therapy, MCHP, MAHE, Manipal

KARNATAKA
576104
India 
Phone  08197579700  
Fax    
Email  shalini.quadros@manipal.edu  
 
Source of Monetary or Material Support  
Manipal College of Health Professions (MCHP), MAHE, Manipal 
 
Primary Sponsor  
Name  Shalini Quadros 
Address  Department of Occupational Therapy, MAHE, Manipal 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
Dr Ravindra N Munoli  Associate Professor, Department of Psychiatry, KMC, Manipal 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ravidra N Munoli  Kasturba Hospital, Manipal  Department of Psychiatry,Room number - 33, Manipal
Udupi
KARNATAKA 
0820-2922217

ravindra.nm@manipal.edu 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Kasturba Medical College and Kasturba Hospital Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: F01-F99||Mental, Behavioral and Neurodevelopmental disorders,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  11.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  • Adults diagnosed with Schizophrenia as per DSM- V criteria by a psychiatrist
• Clients diagnosed with Schizophrenia with a duration of illness more than 1 year
• Scores more than or equal to 17 in Kannada translated version of Hindi Mental Status Examination (HMSE)
 
 
ExclusionCriteria 
Details  • Clients with any long-term comorbid conditions including cancers, chronic respiratory diseases, diabetes, neuro-generative conditions, any other mental health condition 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Occupational Participation as on Model of Human Occupation Screening Tool (MOHOST) and Sensory Modulation as on Adult Sensory Profile (A/ASP)  One time at baseline 
 
Secondary Outcome  
Outcome  TimePoints 
Positive and Negative Symptoms as on PANSS, Disability scores as on WHODAS 2.0, Cognition as on LOTCA  One time at baseline 
 
Target Sample Size   Total Sample Size="138"
Sample Size from India="138" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/01/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Closed to Recruitment of Participants 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

A detailed explanation of the study will be given to the clients diagnosed with schizophrenia and written consent will be obtained from the client and the caregiver. HMSE will be administered and clients scoring equal to or more than 17 will only be included in the study. The severity of symptoms of schizophrenia will be obtained by administering PANSS followed by which the A/ASP and MOHOST will be administered on the client followed by administration of MOHOST. The UKU-SERS-Clin (to measure the side effects), WHODAS 2.0 (to measure the disability level), Kuppuswamy`s socioeconomic status scale will be administered on the participants. The data obtained will be analyzed for a possible relationship between the A/ASP scores MOHOST.  

 
Close